What Researchers Did
Researchers reported on a single case where hyperbaric oxygen therapy was used to treat intractable cyclophosphamide-induced hemorrhagic cystitis.
What They Found
After 8 consecutive weeks of hyperbaric oxygen therapy at an absolute pressure of 2 atm, the patient's bleeding completely ceased. The patient remained free of hematuria thereafter, and no side effects were observed during the course of therapy.
What This Means for Canadian Patients
For Canadian patients experiencing severe hemorrhagic cystitis caused by cyclophosphamide, hyperbaric oxygen therapy could be a potential treatment option. This therapy might offer relief from persistent bleeding when conventional treatments have failed.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A significant limitation of this study is that it is a single case report, which limits the generalizability of its findings to a broader patient population.